MicroRNA signature in liver cancer.


Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 31 12 2020
revised: 31 01 2021
accepted: 02 02 2021
pubmed: 25 2 2021
medline: 4 11 2021
entrez: 24 2 2021
Statut: ppublish

Résumé

Liver cancer is the 7

Identifiants

pubmed: 33626406
pii: S0344-0338(21)00030-3
doi: 10.1016/j.prp.2021.153369
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

153369

Informations de copyright

Copyright © 2021 Elsevier GmbH. All rights reserved.

Auteurs

Soudeh Ghafouri-Fard (S)

Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Kasra Honarmand Tamizkar (K)

Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Bashdar Mahmud Hussen (BM)

Pharmacognosy Department, College of Pharmacy, Hawler Medical University, Erbil, Iraq.

Mohammad Taheri (M)

Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: Mohammad_823@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH